What's Cooking in Drug Discovery
- From zebrafish to diseases-in-a-dish, scientists are seeking alternative routes to find treatments for difficult, incurable diseases
August 29, 2017
BY: Regina McEnery
- How an alternative business model helps companies retain visibility and increase speed to market but remove day-to-day struggles.
August 16, 2017
BY: Ann Murray
- Can multi-targeted drugs lead to improved treatments for Alzheimer’s disease and other illnesses?
August 15, 2017
BY: David Clark
- Among tumors, glioblastomas are among the toughest to treat. But do they have to be a dead end? A discussion with Charles River Immunologist David Harris.
August 3, 2017
BY: Regina McEnery
- PROTAC Mediated Protein Degradation—using small molecules to manipulate our cellular machinery
July 25, 2017
BY: Ian Linney
- Studies suggest that stopping this brain-wasting condition may require early intervention
July 24, 2017
BY: Sonia Vallabh
- Some believe science meetings need to go virtual. Here’s why that would be an unfortunate idea
July 19, 2017
BY: Deborah Dormady Letham
- Animal models are really actors re-creating roles about the course of human diseases. But they can only re-enact part of the story.
July 12, 2017
BY: Regina McEnery
- The drug development terrain can be rocky, particularly for academics. Here are four tips that might help the startup process run more smoothly.
June 26, 2017
BY: Joseph Murphy
- Next-generation business models are emerging through collaborative networks to help move candidates through tough terrain. A Q&A roundtable discussion.
June 21, 2017
BY: Regina McEnery